Efficacy of Platelet-rich Plasma Injection Compare With Corticosteroid in Pes Anserinus Pain Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRamathibodi Hospital
About this trial
The goal of this research is to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis. The research question is whether PRP can reduce pain more effectively than corticosteroids.
The study is divided into two groups: one group receiving PRP injections and the second group receiving corticosteroid injections. Treatment outcomes will be monitored at four time points: baseline, 4 weeks, 12 weeks, and 24 weeks. The outcomes will be measured using the VAS and WOMAC scores.
Eligibility criteria
Qualifiers
Over 18 years old
Patients diagnosed with Pes Anserine Pain Syndrome
Patients willing to participate in the research project by signing a consent form
Disqualifiers
Patients with a localized knee infection or a disseminated infection within the past 3 months
Patients with thyroid disorders, rheumatoid arthritis, or other types of knee arthritis
Patients with abnormal blood coagulation or thrombocytopenia
Patients who are pregnant
Trial design
Treatments tested in this trial
- PRP injection
- corticosteroid injection
Treatment groups
24 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov